interferon 1b recombinant human interferon beta Search Results


93
Gold Biotechnology Inc immunofluorescence buffer
Satellite cell reduction reduces muscle regeneration capacity in cecal ligation and puncture/daily chronic stress (CLP/DCS) mice. ( A ) Timeline representing male Pax7‐DTA mice treated for five consecutive daily injections of tamoxifen or vehicle, 15 days before surgery. Percentage change from baseline of ( B ) lean mass. ( C ) <t>Immunofluorescence</t> images (top) and quantification of minimum Feret diameter (bottom) of tibialis anterior (TA) cross sections from either vehicle or tamoxifen control and CLP/DCS mice. Green = laminin, Blue = DAPI. Images are ×20 with scale bar = 200 μm. ( D ) Pax7 staining (top) and quantification of Pax7‐positive nuclei per myofibre (bottom) of tibialis anterior (TA) cross‐sections from vehicle or tamoxifen control and CLP/DCS mice. Purple = haematoxylin (nuclei), Red = Pax7. Images are ×40 with scale bar = 50 μm. All images are representative. B = Two‐way ANOVA with Bonferroni multiple comparisons (BMC) where *significant vs. control vehicle and control tamoxifen, ^significant vs. control tamoxifen, and % significant vs. control vehicle, P < 0.05. C = nonlinear fit pairwise comparisons. D = One‐way ANOVA with BMC where significance = * P < 0.05, ** P < 0.01, *** P < 0.001. See Tables <xref ref-type= S4 and S5 for all P values from all comparisons in ( B ) and ( C ), respectively. N = 3–7. Each n = one mouse. " width="250" height="auto" />
Immunofluorescence Buffer, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/interferon+1b+recombinant+human+interferon+beta/pmc10235871-59-21-29?v=Gold+Biotechnology+Inc
Average 93 stars, based on 1 article reviews
immunofluorescence buffer - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

90
Barofold Inc recombinant human ifn beta baroferontm
Satellite cell reduction reduces muscle regeneration capacity in cecal ligation and puncture/daily chronic stress (CLP/DCS) mice. ( A ) Timeline representing male Pax7‐DTA mice treated for five consecutive daily injections of tamoxifen or vehicle, 15 days before surgery. Percentage change from baseline of ( B ) lean mass. ( C ) <t>Immunofluorescence</t> images (top) and quantification of minimum Feret diameter (bottom) of tibialis anterior (TA) cross sections from either vehicle or tamoxifen control and CLP/DCS mice. Green = laminin, Blue = DAPI. Images are ×20 with scale bar = 200 μm. ( D ) Pax7 staining (top) and quantification of Pax7‐positive nuclei per myofibre (bottom) of tibialis anterior (TA) cross‐sections from vehicle or tamoxifen control and CLP/DCS mice. Purple = haematoxylin (nuclei), Red = Pax7. Images are ×40 with scale bar = 50 μm. All images are representative. B = Two‐way ANOVA with Bonferroni multiple comparisons (BMC) where *significant vs. control vehicle and control tamoxifen, ^significant vs. control tamoxifen, and % significant vs. control vehicle, P < 0.05. C = nonlinear fit pairwise comparisons. D = One‐way ANOVA with BMC where significance = * P < 0.05, ** P < 0.01, *** P < 0.001. See Tables <xref ref-type= S4 and S5 for all P values from all comparisons in ( B ) and ( C ), respectively. N = 3–7. Each n = one mouse. " width="250" height="auto" />
Recombinant Human Ifn Beta Baroferontm, supplied by Barofold Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/interferon+1b+recombinant+human+interferon+beta/10__2147_slash_btt__s29948-67-14-0?v=Barofold+Inc
Average 90 stars, based on 1 article reviews
recombinant human ifn beta baroferontm - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Enzon Inc recombinant human interferon-beta-1b (30 miu/mg)
Satellite cell reduction reduces muscle regeneration capacity in cecal ligation and puncture/daily chronic stress (CLP/DCS) mice. ( A ) Timeline representing male Pax7‐DTA mice treated for five consecutive daily injections of tamoxifen or vehicle, 15 days before surgery. Percentage change from baseline of ( B ) lean mass. ( C ) <t>Immunofluorescence</t> images (top) and quantification of minimum Feret diameter (bottom) of tibialis anterior (TA) cross sections from either vehicle or tamoxifen control and CLP/DCS mice. Green = laminin, Blue = DAPI. Images are ×20 with scale bar = 200 μm. ( D ) Pax7 staining (top) and quantification of Pax7‐positive nuclei per myofibre (bottom) of tibialis anterior (TA) cross‐sections from vehicle or tamoxifen control and CLP/DCS mice. Purple = haematoxylin (nuclei), Red = Pax7. Images are ×40 with scale bar = 50 μm. All images are representative. B = Two‐way ANOVA with Bonferroni multiple comparisons (BMC) where *significant vs. control vehicle and control tamoxifen, ^significant vs. control tamoxifen, and % significant vs. control vehicle, P < 0.05. C = nonlinear fit pairwise comparisons. D = One‐way ANOVA with BMC where significance = * P < 0.05, ** P < 0.01, *** P < 0.001. See Tables <xref ref-type= S4 and S5 for all P values from all comparisons in ( B ) and ( C ), respectively. N = 3–7. Each n = one mouse. " width="250" height="auto" />
Recombinant Human Interferon Beta 1b (30 Miu/Mg), supplied by Enzon Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/interferon+1b+recombinant+human+interferon+beta/pm16536464-60-0-8?v=Enzon+Inc
Average 90 stars, based on 1 article reviews
recombinant human interferon-beta-1b (30 miu/mg) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

N/A
Interferon beta 1b Human Recombinant produced in E.Coli is a single, non-glycosylated mutein (variant form) of human Interferon beta-1b polypeptide chain containing 165 amino acids and having a molecular mass of 18510.86 Dalton.The IFN-beta gene
  Buy from Supplier

N/A
The Recombinant Human Interferon beta 1b Protein from Novus Biologicals is derived from E coli The Recombinant Human Interferon beta 1b Protein has been validated for the following applications Functional SDS Page
  Buy from Supplier

N/A
IFN b 1b; Recombinant Human Interferon-beta 1b; Recombinant Human Interferon-beta 1b
  Buy from Supplier

N/A
Purified recombinant Interferon beta 1b expressed in E. coli.
  Buy from Supplier

N/A
Interferon-Beta 1b, Human Recombinant; 10 ug
  Buy from Supplier

Image Search Results


Satellite cell reduction reduces muscle regeneration capacity in cecal ligation and puncture/daily chronic stress (CLP/DCS) mice. ( A ) Timeline representing male Pax7‐DTA mice treated for five consecutive daily injections of tamoxifen or vehicle, 15 days before surgery. Percentage change from baseline of ( B ) lean mass. ( C ) Immunofluorescence images (top) and quantification of minimum Feret diameter (bottom) of tibialis anterior (TA) cross sections from either vehicle or tamoxifen control and CLP/DCS mice. Green = laminin, Blue = DAPI. Images are ×20 with scale bar = 200 μm. ( D ) Pax7 staining (top) and quantification of Pax7‐positive nuclei per myofibre (bottom) of tibialis anterior (TA) cross‐sections from vehicle or tamoxifen control and CLP/DCS mice. Purple = haematoxylin (nuclei), Red = Pax7. Images are ×40 with scale bar = 50 μm. All images are representative. B = Two‐way ANOVA with Bonferroni multiple comparisons (BMC) where *significant vs. control vehicle and control tamoxifen, ^significant vs. control tamoxifen, and % significant vs. control vehicle, P < 0.05. C = nonlinear fit pairwise comparisons. D = One‐way ANOVA with BMC where significance = * P < 0.05, ** P < 0.01, *** P < 0.001. See Tables <xref ref-type= S4 and S5 for all P values from all comparisons in ( B ) and ( C ), respectively. N = 3–7. Each n = one mouse. " width="100%" height="100%">

Journal: Journal of Cachexia, Sarcopenia and Muscle

Article Title: Muscle stem cells contribute to long‐term tissue repletion following surgical sepsis

doi: 10.1002/jcsm.13214

Figure Lengend Snippet: Satellite cell reduction reduces muscle regeneration capacity in cecal ligation and puncture/daily chronic stress (CLP/DCS) mice. ( A ) Timeline representing male Pax7‐DTA mice treated for five consecutive daily injections of tamoxifen or vehicle, 15 days before surgery. Percentage change from baseline of ( B ) lean mass. ( C ) Immunofluorescence images (top) and quantification of minimum Feret diameter (bottom) of tibialis anterior (TA) cross sections from either vehicle or tamoxifen control and CLP/DCS mice. Green = laminin, Blue = DAPI. Images are ×20 with scale bar = 200 μm. ( D ) Pax7 staining (top) and quantification of Pax7‐positive nuclei per myofibre (bottom) of tibialis anterior (TA) cross‐sections from vehicle or tamoxifen control and CLP/DCS mice. Purple = haematoxylin (nuclei), Red = Pax7. Images are ×40 with scale bar = 50 μm. All images are representative. B = Two‐way ANOVA with Bonferroni multiple comparisons (BMC) where *significant vs. control vehicle and control tamoxifen, ^significant vs. control tamoxifen, and % significant vs. control vehicle, P < 0.05. C = nonlinear fit pairwise comparisons. D = One‐way ANOVA with BMC where significance = * P < 0.05, ** P < 0.01, *** P < 0.001. See Tables S4 and S5 for all P values from all comparisons in ( B ) and ( C ), respectively. N = 3–7. Each n = one mouse.

Article Snippet: Permeabilization was performed using 0.5% Triton X‐100 (Sigma) in PBS for 5 min at room temperature (RT), then washed ×2 in immunofluorescence buffer (IFB: 3% bovine serum albumin [BSA, GoldBio], 0.2% Triton X‐100 (Sigma), 0.2% Tween‐20 [Sigma], in PBS).

Techniques: Ligation, Immunofluorescence, Control, Staining

Characterization of muscle loss and recovery in CLP/DCS mice. ( A ) Combined cecal ligation and puncture (CLP)/daily chronic stress (DCS) Kaplan–Meier survival curve versus control mice to experiment endpoint. ( B ) Serum levels of mouse C‐reactive protein (CRP) and aspartate aminotransferase (AST) activity. ( C ) Control and CLP/DCS percentage change from baseline in lean mass. Data from mouse MRI on Day 3 or 4 are represented on lean mass graph as Day 3. ( D ) Harvested wet weights, as change in percentage of control, of tibialis anterior (TA, top) and gastrocnemius (GR, bottom) normalized to baseline body weight, respectively, in control and CLP/DCS Days 4, 8 and 28. ( E ) Immunofluorescence images (top) and quantification of minimum Feret diameter (bottom) of tibialis anterior (TA) cross‐sections from control, Days 4, 8 and 28 CLP/DCS mice. Green = laminin, Blue = DAPI. Images are representative and ×20 with scale bar = 200 μm. See Table <xref ref-type= S1 for all P value comparisons. ( F ) Immunofluorescence images (top) and quantification (bottom) of tibialis anterior (TA) myofibre typing from control, Days 4, 8 and 28 CLP/DCS mice. Red = type IIb, Green = type IIa, Unstained = type IIx, White = laminin. Images are representative and ×20 with scale bar = 100 μm. Data from muscle mass/minimum Feret diameter/myofibre typing were harvested on Day 27 or 28 and are labelled as Day 28. B = log‐rank test. C , E , G = One‐way ANOVA with Bonferroni multiple comparisons (BMC). D = Two‐way ANOVA with BMC. F = nonlinear fit pairwise comparisons. Significance: * P < 0.05, **/ & P < 0.01, ***/ # P < 0.001. ( B ) n = 12–13. ( C–D ) n = 16–45. ( E ) n = 11–14. ( F ) n = 5. ( G ) n = 10–14. Each n = one mouse. " width="100%" height="100%">

Journal: Journal of Cachexia, Sarcopenia and Muscle

Article Title: Muscle stem cells contribute to long‐term tissue repletion following surgical sepsis

doi: 10.1002/jcsm.13214

Figure Lengend Snippet: Characterization of muscle loss and recovery in CLP/DCS mice. ( A ) Combined cecal ligation and puncture (CLP)/daily chronic stress (DCS) Kaplan–Meier survival curve versus control mice to experiment endpoint. ( B ) Serum levels of mouse C‐reactive protein (CRP) and aspartate aminotransferase (AST) activity. ( C ) Control and CLP/DCS percentage change from baseline in lean mass. Data from mouse MRI on Day 3 or 4 are represented on lean mass graph as Day 3. ( D ) Harvested wet weights, as change in percentage of control, of tibialis anterior (TA, top) and gastrocnemius (GR, bottom) normalized to baseline body weight, respectively, in control and CLP/DCS Days 4, 8 and 28. ( E ) Immunofluorescence images (top) and quantification of minimum Feret diameter (bottom) of tibialis anterior (TA) cross‐sections from control, Days 4, 8 and 28 CLP/DCS mice. Green = laminin, Blue = DAPI. Images are representative and ×20 with scale bar = 200 μm. See Table S1 for all P value comparisons. ( F ) Immunofluorescence images (top) and quantification (bottom) of tibialis anterior (TA) myofibre typing from control, Days 4, 8 and 28 CLP/DCS mice. Red = type IIb, Green = type IIa, Unstained = type IIx, White = laminin. Images are representative and ×20 with scale bar = 100 μm. Data from muscle mass/minimum Feret diameter/myofibre typing were harvested on Day 27 or 28 and are labelled as Day 28. B = log‐rank test. C , E , G = One‐way ANOVA with Bonferroni multiple comparisons (BMC). D = Two‐way ANOVA with BMC. F = nonlinear fit pairwise comparisons. Significance: * P < 0.05, **/ & P < 0.01, ***/ # P < 0.001. ( B ) n = 12–13. ( C–D ) n = 16–45. ( E ) n = 11–14. ( F ) n = 5. ( G ) n = 10–14. Each n = one mouse.

Article Snippet: Permeabilization was performed using 0.5% Triton X‐100 (Sigma) in PBS for 5 min at room temperature (RT), then washed ×2 in immunofluorescence buffer (IFB: 3% bovine serum albumin [BSA, GoldBio], 0.2% Triton X‐100 (Sigma), 0.2% Tween‐20 [Sigma], in PBS).

Techniques: Ligation, Control, Activity Assay, Immunofluorescence

Muscle recovery deficit in post‐sepsis mice with secondary muscle injury. ( A ) Timeline depicting experimental setup of second insult to muscle in control and cecal ligation and puncture/daily chronic stress (CLP/DCS) mice. ( B ) Immunofluorescence images (top) and minimum Feret diameter quantification (bottom) of tibialis anterior (TA) cross‐sections in control or CLP/DCS mice that received vehicle or BaCl 2 (injured) injections. Green = laminin, Blue = DAPI. Images are ×20 with scale bar = 200 μm. ( C ) Pax7 staining (top) and quantification of Pax7‐postive nuclei per myofibre of TA cross‐sections from vehicle or injured control and CLP/DCS mice. Purple = haematoxylin (nuclei), Red = Pax7. Images are ×40 with scale bar = 50 μm. All images are representative. B = nonlinear fit pairwise comparisons, see Table <xref ref-type= S6 for all P values from all comparisons. C = One‐way ANOVA with Bonferroni multiple comparisons (BMC). Significance is * P < 0.05, ** P < 0.01, *** P < 0.001. N = 3–6. Each n = one mouse. " width="100%" height="100%">

Journal: Journal of Cachexia, Sarcopenia and Muscle

Article Title: Muscle stem cells contribute to long‐term tissue repletion following surgical sepsis

doi: 10.1002/jcsm.13214

Figure Lengend Snippet: Muscle recovery deficit in post‐sepsis mice with secondary muscle injury. ( A ) Timeline depicting experimental setup of second insult to muscle in control and cecal ligation and puncture/daily chronic stress (CLP/DCS) mice. ( B ) Immunofluorescence images (top) and minimum Feret diameter quantification (bottom) of tibialis anterior (TA) cross‐sections in control or CLP/DCS mice that received vehicle or BaCl 2 (injured) injections. Green = laminin, Blue = DAPI. Images are ×20 with scale bar = 200 μm. ( C ) Pax7 staining (top) and quantification of Pax7‐postive nuclei per myofibre of TA cross‐sections from vehicle or injured control and CLP/DCS mice. Purple = haematoxylin (nuclei), Red = Pax7. Images are ×40 with scale bar = 50 μm. All images are representative. B = nonlinear fit pairwise comparisons, see Table S6 for all P values from all comparisons. C = One‐way ANOVA with Bonferroni multiple comparisons (BMC). Significance is * P < 0.05, ** P < 0.01, *** P < 0.001. N = 3–6. Each n = one mouse.

Article Snippet: Permeabilization was performed using 0.5% Triton X‐100 (Sigma) in PBS for 5 min at room temperature (RT), then washed ×2 in immunofluorescence buffer (IFB: 3% bovine serum albumin [BSA, GoldBio], 0.2% Triton X‐100 (Sigma), 0.2% Tween‐20 [Sigma], in PBS).

Techniques: Control, Ligation, Immunofluorescence, Staining